NDC 10157-9409 - Blistex Baby Kanka
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10157-9409
- Package NDCs from labels
- 10157-9409-1
- Manufacturer
- Blistex Inc.
- Effective date
- 2015-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Blistex Baby Kanka ® Gel | Blistex Inc. | 2015-01-22 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9409-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-dd11-f424-e053-dadaa90a57ce | Blistex Baby Kanka ® Gel |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9409-1 | Blistex Baby Kanka | 10 g in 1 TUBE | GEL | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9409 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | 1 package rows | 20150129_b70ff808-43d3-4a14-867e-b56f9db9da87.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oral Gel Oral Pain Relief | BENZOCAINE BENZALKONIUM CHLORIDE | Savvy Care and Cosmetics | 05ede7e4-5a0a-c942-e063-6294a90a8a24 | 2024-12-19 | Warnings | U3RSY48JW5 |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Pain, Burn, and Itch Relief | BENZOCAINE 20%, MENTHOL 0.5% | Derma Care Research Labs, LLC | fd9fe09f-3ae9-c5f5-e053-6394a90ad691 | 2024-12-19 | Warnings | U3RSY48JW5 |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| Red Cross Oral Pain Relief | BENZOCAINE | The Mentholatum Company | cbd41429-f730-4577-9f06-ef1831cf62e1 | 2024-12-17 | Warnings | U3RSY48JW5 |
| Red Cross Canker Sore | BENZOCAINE | The Mentholatum Company | 54cfff96-6665-4b36-a15d-10bf6cf3a1f9 | 2024-12-17 | Warnings | U3RSY48JW5 |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Chiggerex | BENZOCAINE | RANDOB LABS, LTD. DBA CROSSINGWELL CONSUMER HEALTH | 5e5d84ab-f57f-448d-a4c1-ced38890eec2 | 2024-12-17 | Warnings | U3RSY48JW5 |
| Kank-A Mouth Pain | BENZOCAINE | Blistex Inc. | eebc03ba-f849-4e70-a653-834f383b6aa4 | 2024-12-17 | Warnings | U3RSY48JW5 |
| Topicale | BENZOCAINE | Medical Products Laboratories, Inc. | 8282a4a6-b77c-75fc-e053-2991aa0ad4ac | 2024-12-16 | Warnings | U3RSY48JW5 |
| Topicale Xtra | BENZOCAINE | Medical Products Laboratories,Inc. | 9452bff4-8c08-eff9-e053-2a95a90a67ed | 2024-12-16 | Warnings | U3RSY48JW5 |
| Rite Aid Pain Relieving | BENZOCAINE 20%, MENTHOL 0.5% | Rite Aid | e2c09e85-be0a-4e6d-e053-2995a90ad756 | 2024-12-15 | Warnings | U3RSY48JW5 |
| Warrior Chiggerex Relief | BENZOCAINE 10% | Derma Care Research Labs, LLC | dcf2f52b-2295-58e5-e053-2995a90a7fd8 | 2024-12-15 | Warnings | U3RSY48JW5 |
| Household Detox | ALLIUM SATIVUM, ALUMINA, ANTIPYRINUM, BENZINUM, BISPHENOL A, CARBOLICUM ACIDUM, CARBONEUM SULPHURATUM, DIETHYLSTILBESTROL, DIOXIN, FOLLICULINUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PARAFFINUM, PETROLEUM, PHENACETINUM, PTELEA TRIFOLIATA, SODIUM CARBOXYMETHYL CELLULOSE, TEFLON | Deseret Biologicals, Inc. | 7f79058a-c35a-429a-be3c-4cff1d657087 | 2024-12-13 | Warnings | A2I8C7HI9T |
| Dermoplast Kids First Aid | BENZETHONIUM CHLORIDE AND BENZOCAINE | Advantice Health, LLC. | 29a18018-5214-4080-ac40-e646319e95ce | 2024-12-12 | Warnings | U3RSY48JW5 |
| Dermoplast Pain Relieving | BENZOCAINE AND LEVOMENTHOL | Advantice Health, LLC | 2347f0b8-d463-422d-8583-65624d9a1a91 | 2024-12-12 | Warnings | U3RSY48JW5 |
| KANKA SoftBrush | BENZOCAINE AND ZINC CHLORIDE | Blistex Inc | 093f3545-1d8e-48a3-a533-e9c3ae6d740b | 2024-12-12 | Warnings | U3RSY48JW5 |
| VAGISIL Anti-Itch Medicated Creme Maximum Strength | BENZOCAINE AND RESORCINOL | Combe Incorporated | bb73ebd7-ceb0-4b54-9e8f-77486d9037fb | 2024-12-12 | Warnings | U3RSY48JW5 |
| VAGISIL Anti-Itch Creme Regular Strength | BENZOCAINE AND RESORCINOL | Combe Incorporated | dd303ff8-0deb-4292-bfd8-5bda91f86d51 | 2024-12-12 | Warnings | U3RSY48JW5 |
| Topicale | BENZOCAINE | Medical Products Laboratories, Inc. | 826eaef8-4457-3dc2-e053-2991aa0a528b | 2024-12-11 | Warnings | U3RSY48JW5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.